Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludarabine, work in
different ways to stop tumor cells from dividing so they stop growing or die. Interleukin-2
may stimulate a person's white blood cells to kill tumor cells and may help a person's immune
system recover from the side effects of chemotherapy.
PURPOSE: This phase II trial is studying how well giving cyclophosphamide and fludarabine
together with high-dose interleukin-2 works in treating patients with metastatic melanoma.